Advanced search
Publication Cover
OncoImmunology Volume 5, 2016 - Issue 7
Submit an article Journal homepage
2,582
Views
19
CrossRef citations to date
0
Altmetric
Original Research

Proof of concept study with an HER-2 mimotope anticancer vaccine deduced from a novel AAV-mimotope library platform

Josef SingerCenter of Pathophysiology, Infectiology and Immunology, Institute of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria;Biomedical International R+D GmbH, Vienna, Austria
,
Krisztina Manzano-SzalaiBiomedical International R+D GmbH, Vienna, Austria;Comparative Medicine, Messerli Research Institute of the University of Veterinary Medicine Vienna, Medical University Vienna, and University Vienna, Vienna, Austria
,
Judit FazekasCenter of Pathophysiology, Infectiology and Immunology, Institute of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria;Comparative Medicine, Messerli Research Institute of the University of Veterinary Medicine Vienna, Medical University Vienna, and University Vienna, Vienna, Austria
,
Kathrin ThellCenter of Pathophysiology, Infectiology and Immunology, Institute of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria;Biomedical International R+D GmbH, Vienna, Austria
,
Anna Bentley-LukschalCenter of Pathophysiology, Infectiology and Immunology, Institute of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria
,
Caroline StremnitzerCenter of Pathophysiology, Infectiology and Immunology, Institute of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria
,
Franziska Roth-WalterComparative Medicine, Messerli Research Institute of the University of Veterinary Medicine Vienna, Medical University Vienna, and University Vienna, Vienna, Austria
,
Margit WeghoferMediGene AG, Martinsried, Germany
,
Mirko RitterMediGene AG, Martinsried, Germany
,
Kerstin Pino TossiMediGene AG, Martinsried, Germany
,
Markus HörerMediGene AG, Martinsried, Germany
,
Uwe MichaelisMediGene AG, Martinsried, Germany;ImevaX GmbH Munich, Germany
&
Erika Jensen-JarolimCenter of Pathophysiology, Infectiology and Immunology, Institute of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria;Biomedical International R+D GmbH, Vienna, Austria;Comparative Medicine, Messerli Research Institute of the University of Veterinary Medicine Vienna, Medical University Vienna, and University Vienna, Vienna, AustriaCorrespondence[email protected]
 show all
Article: e1171446 | Received 27 Jan 2016, Accepted 21 Mar 2016, Published online: 30 Jun 2016

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Adam F. Sander & Pier-Luigi Lollini. (2018) Virus-like antigen display for cancer vaccine development, what is the potential?. Expert Review of Vaccines 17:4, pages 285-288.
Read now

Articles from other publishers (18)

Esmeralda Cuevas‐Juárez, Arturo Liñan‐Torres, Carolina Hernández, Mykhailo Kopylov, Clint S. Potter, Bridget Carragher, Octavio T. Ramírez & Laura A. Palomares. (2023) Mimotope discovery as a tool to design a vaccine against Zika and dengue viruses. Biotechnology and Bioengineering 120:9, pages 2658-2671.
Crossref
Junrui Tian & Jian Ma. (2023) The Value of Microbes in Cancer Neoantigen Immunotherapy. Pharmaceutics 15:8, pages 2138.
Crossref
Weixun Peng. (2023) Roles of Virus-like particles in particularcancer vaccines. Highlights in Science, Engineering and Technology 36, pages 1517-1524.
Crossref
Atefeh Arab, Amin Reza Nikpoor, Peyman Asadi, Reza Iraei, Rezvan Yazdian-Robati, Afsana Sheikh & Prashant Kesharwani. (2022) Virus-like nanoparticles (VLPs) based technology in the development of breast cancer ‎vaccines‎. Process Biochemistry 123, pages 44-51.
Crossref
Joshua Tobias, Mirjana Drinić, Anna Schmid, Anastasiya Hladik, Martin L. Watzenböck, Claire Battin, Erika Garner-Spitzer, Peter Steinberger, Michael Kundi, Sylvia Knapp, Christoph C. Zielinski & Ursula Wiedermann. (2022) Combined Vaccination with B Cell Peptides Targeting Her-2/neu and Immune Checkpoints as Emerging Treatment Option in Cancer. Cancers 14:22, pages 5678.
Crossref
Dinh To Le, Marco T. Radukic, Kathrin Teschner, Lukas Becker & Kristian M. Müller. (2022) Synthesis and Concomitant Assembly of Adeno-Associated Virus-like Particles in Escherichia coli . ACS Synthetic Biology 11:11, pages 3601-3607.
Crossref
Masoud Delfi, Rossella Sartorius, Milad Ashrafizadeh, Esmaeel Sharifi, Yapei Zhang, Piergiuseppe De Berardinis, Ali Zarrabi, Rajender S. Varma, Franklin R. Tay, Bryan Ronain Smith & Pooyan Makvandi. (2021) Self-assembled peptide and protein nanostructures for anti-cancer therapy: Targeted delivery, stimuli-responsive devices and immunotherapy. Nano Today 38, pages 101119.
Crossref
Morgan Brisse, Sophia M. Vrba, Natalie Kirk, Yuying Liang & Hinh Ly. (2020) Emerging Concepts and Technologies in Vaccine Development. Frontiers in Immunology 11.
Crossref
Anne C. Conibear, Alanca Schmid, Meder Kamalov, Christian F.W. Becker & Claudia Bello. (2020) Recent Advances in Peptide-Based Approaches for Cancer Treatment. Current Medicinal Chemistry 27:8, pages 1174-1205.
Crossref
Martina Goracci, Ymera Pignochino & Serena Marchiò. (2020) Phage Display-Based Nanotechnology Applications in Cancer Immunotherapy. Molecules 25:4, pages 843.
Crossref
Winfrey Pui Yee Hoo, Pui Yan Siak & Lionel L.A. In. (2019) Overview of Current Immunotherapies Targeting Mutated KRAS Cancers. Current Topics in Medicinal Chemistry 19:23, pages 2158-2175.
Crossref
Mona Pourjafar, Pouria Samadi, Hamed Manoochehri Khoshinani & Massoud Saidijam. (2019) Are mimotope vaccines a good alternative to monoclonal antibodies?. Immunotherapy 11:9, pages 795-800.
Crossref
Hui Cai, Sourabh Shukla, Chao Wang, Hema Masarapu & Nicole F. Steinmetz. (2019) Heterologous Prime-Boost Enhances the Antitumor Immune Response Elicited by Plant-Virus-Based Cancer Vaccine. Journal of the American Chemical Society 141:16, pages 6509-6518.
Crossref
Hildegard Büning & Arun Srivastava. (2019) Capsid Modifications for Targeting and Improving the Efficacy of AAV Vectors. Molecular Therapy - Methods & Clinical Development 12, pages 248-265.
Crossref
Josef Singer, Gertrude Achatz-Straussberger, Anna Bentley-Lukschal, Judit Fazekas-Singer, Gernot Achatz, Sophia N. Karagiannis & Erika Jensen-Jarolim. (2019) AllergoOncology: High innate IgE levels are decisive for the survival of cancer-bearing mice. World Allergy Organization Journal 12:7, pages 100044.
Crossref
Ludger Klimek, Thomas Kündig, Matthias F. Kramer, Sonja Guethoff, Erika Jensen-Jarolim, Carsten B. Schmidt-Weber, Oskar Palomares, Mona O. Mohsen, Thilo Jakob & Martin Bachmann. (2018) Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases. Allergo Journal International 27:8, pages 245-255.
Crossref
Ludger Klimek, Thomas Kündig, Matthias F. Kramer, Sonja Guethoff, Erika Jensen-Jarolim, Carsten B. Schmidt-Weber, Oscar Palomares, Mona O. Mohsen, Thilo Jakob & Martin Bachmann. (2018) Virus-like particles in der Prophylaxe und Immuntherapie allergischer Erkrankungen. Allergo Journal 27:8, pages 22-33.
Crossref
Judit Fazekas, Irene Fürdös, Josef Singer & Erika Jensen-Jarolim. (2016) Why man's best friend, the dog, could also benefit from an anti-HER-2 vaccine. Oncology Letters 12:4, pages 2271-2276.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.